Landscape Capital Management, L.L.C. Trevi Therapeutics, Inc. Transaction History
Landscape Capital Management, L.L.C.
- $835 Million
- Q4 2024
A detailed history of Landscape Capital Management, L.L.C. transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Landscape Capital Management, L.L.C. holds 52,085 shares of TRVI stock, worth $223,965. This represents 0.03% of its overall portfolio holdings.
Number of Shares
52,085
Previous 424,725
87.74%
Holding current value
$223,965
Previous $1.42 Million
84.41%
% of portfolio
0.03%
Previous 0.16%
Shares
5 transactions
Others Institutions Holding TRVI
# of Institutions
114Shares Held
77.6MCall Options Held
218KPut Options Held
182K-
Nea Management Company, LLC Timonium, MD11.4MShares$48.9 Million3.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.7MShares$45.9 Million2.72% of portfolio
-
Viking Global Investors LP4.4MShares$18.9 Million0.06% of portfolio
-
Rubric Capital Management LP New York, NY4.21MShares$18.1 Million0.3% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.15MShares$17.8 Million0.04% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $251M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...